3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Conditions
Prostatic Neoplasms
17
Neoplasms
13
Breast Neoplasms
12
Neuroendocrine Tumors
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Neoplasm Metastasis
6
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Multiple Myeloma
4
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mouth Neoplasms
3
Lymphoma, Non-Hodgkin
3
Glioma
3
Esophageal Squamous Cell Carcinoma
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplastic Cells, Circulating
2
Nasopharyngeal Carcinoma
2
Multiple Pulmonary Nodules
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Hypoxia
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Doxorubicin
69
Radiotherapy
50
Ifosfamide
48
Gemcitabine
43
Cyclophosphamide
36
pazopanib
29
Filgrastim
28
pembrolizumab
26
Docetaxel
26
Nivolumab
23
Surgical Procedures, Operative
21
Etoposide
21
Cisplatin
21
Trabectedin
19
Blood Specimen Collection
19
Carboplatin
15
Radiation
14
Magnetic Resonance Spectroscopy
14
Vincristine
13
Bevacizumab
13
anlotinib
12
Temozolomide
12
Peripheral Blood Stem Cell Transplantation
12
Ipilimumab
12
liposomal doxorubicin
11
apatinib
11
Radiosurgery
11
Neoadjuvant Therapy
11
Melphalan
11
Surveys and Questionnaires
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled